<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03816046</url>
  </required_header>
  <id_info>
    <org_study_id>usj-05</org_study_id>
    <nct_id>NCT03816046</nct_id>
  </id_info>
  <brief_title>Hyperhydrosis Treatment Using Botulinum Toxin</brief_title>
  <official_title>The Quadrant vs the Six Injection Technique in Primary Focal Hyperhidrosis Using Botulinum Toxin: a Cross-over Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St Joseph University, Beirut, Lebanon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St Joseph University, Beirut, Lebanon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe two safe and reproducible techniques for the
      treatment of hyperhidrosis using botulinum toxin. The same patient will receive two different
      injection technique in each armpit and will be evaluated subjectively and objectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The abobotulinumtoxinA (ABO) will be used in all patients. The ABO will be prepared by adding
      4 cc of normal saline to a 500-unit DysportÂ© (Ipsen Ltd, Berks, UK) vial Preinjection patient
      pictures will be taken showing the technique used for each armpit.

      Injection technique:

        1. Technique 1 The Quadrant technique: 5 vertical lines and 5 horizontal lines will be draw
           on the hair bearing area of the armpit amounting to 25 injection points being more
           concentrated on the center. Each injection consists of 5Units of abobotulinum

        2. Technique 2 the six injection technique: will consist on 6 injections in the hair
           bearing area equally spaced with each consisting of 8units

      Follow up will be done at 15 days for post injection pictures with iodine starch test A total
      of 15 male patients will be recruited. And the injection for each armpit in a given patient
      is randomized.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Actual">January 1, 2019</completion_date>
  <primary_completion_date type="Actual">July 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>describe two safe and reproducible techniques for the treatment of hyperhidrosis using botulinum toxin. The same patient will receive two different injection technique in each armpit and will be evaluated subjectively and objectively.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>the objective assessment with iodine starch test</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>objective iodine startch</measure>
    <time_frame>3weeks</time_frame>
    <description>Objective assessment will be done using the iodine starch after a 5 min jumping jack on the post injection visit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>subjective: patient satisfaction</measure>
    <time_frame>3 weeks</time_frame>
    <description>Patient satisfaction will be determined by a questionnaire completed at 3 weeks post-treatment. Subjects will indicate how satisfied they are on a 4-point scale (1-4) as follow:
Very Satisfied
Satisfied
Dissatisfied
Very Dissatisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>subjective: pain on injection</measure>
    <time_frame>day 0</time_frame>
    <description>A verbal scale from 1-10 will be addressed for every patient and every armpit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Hyperhidrosis</condition>
  <arm_group>
    <arm_group_label>Technique 1 The Quadrant technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: 25 Botulinum Toxin injections. 5 vertical lines and 5 horizontal lines will be draw on the hair bearing area of the armpit amounting to 25 injection points being more concentrated on the center. Each injection consists of 5Units of abobotulinum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Technique 2 the six injection technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: 6 Botulinum Toxin injections. will consist on 6 injections in the hair bearing area equally spaced with each consisting of 8units</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>botulinum toxin A</intervention_name>
    <description>injection in hair bearing area of armpits</description>
    <arm_group_label>Technique 1 The Quadrant technique</arm_group_label>
    <arm_group_label>Technique 2 the six injection technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Consecutive 15 male patients presenting to our clinic for primary localized hyperhidrosis
        will be included in this study

        Exclusion Criteria:

          -  Patient that has received a botulinum injection in the past year

        Patient that had a liposuction in the armpit or laser for the hair

        Patients with preexisting neuromuscular conditions (myasthenia gravis, Eaton Lambert
        syndrome) Patients using medication that could potentiate the effect of botulinum (ex:
        aminoglycoside antibiotics) Patients with sensitivity to botulinum toxin or human albumin
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hotel Dieu de France</name>
      <address>
        <city>Beirut</city>
        <zip>0000</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>June 12, 2017</study_first_submitted>
  <study_first_submitted_qc>January 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2019</study_first_posted>
  <last_update_submitted>January 20, 2019</last_update_submitted>
  <last_update_submitted_qc>January 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St Joseph University, Beirut, Lebanon</investigator_affiliation>
    <investigator_full_name>samer jabbour</investigator_full_name>
    <investigator_title>M.D</investigator_title>
  </responsible_party>
  <keyword>botulinum toxim</keyword>
  <keyword>abobotulinum</keyword>
  <keyword>hyperhydrosis</keyword>
  <keyword>injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperhidrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

